Speaker illustration

Doctor Kamal Matli

Lebanese American University, Beirut (Lebanon)

Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study

Event: ESC Congress 2022

Topic: Anticoagulants

Session: Challenges and advances in antithrombotic therapy


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb